$RGEN
REPLIGEN CORP

2017 Q2 Form 10-Q Financial Statement

#000119312517247408 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $32.46M $29.17M
YoY Change 11.26% 35.95%
Cost Of Revenue $13.94M $12.64M
YoY Change 10.23% 47.26%
Gross Profit $18.52M $16.53M
YoY Change 12.05% 28.4%
Gross Profit Margin 57.06% 56.65%
Selling, General & Admin $11.19M $8.140M
YoY Change 37.41% 30.41%
% of Gross Profit 60.4% 49.26%
Research & Development $1.860M $1.890M
YoY Change -1.59% 50.96%
% of Gross Profit 10.04% 11.44%
Depreciation & Amortization $1.700M $1.320M
YoY Change 28.79% 14.78%
% of Gross Profit 9.18% 7.99%
Operating Expenses $26.98M $10.03M
YoY Change 169.01% 33.84%
Operating Profit $5.473M $5.859M
YoY Change -6.59% 27.12%
Interest Expense $1.601M $638.0K
YoY Change 150.94% 7875.0%
% of Operating Profit 29.25% 10.89%
Other Income/Expense, Net -$328.0K $75.00K
YoY Change -537.33% -127.88%
Pretax Income $3.654M $5.372M
YoY Change -31.98% 23.47%
Income Tax -$4.784M $1.500M
% Of Pretax Income -130.93% 27.92%
Net Earnings $8.438M $3.872M
YoY Change 117.92% 7.17%
Net Earnings / Revenue 26.0% 13.27%
Basic Earnings Per Share $0.25 $0.12
Diluted Earnings Per Share $0.24 $0.11
COMMON SHARES
Basic Shares Outstanding 34.10M shares 33.65M shares
Diluted Shares Outstanding 35.09M shares 34.18M shares

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.0M $181.8M
YoY Change -20.24% 187.66%
Cash & Equivalents $142.2M $172.6M
Short-Term Investments $2.700M $9.200M
Other Short-Term Assets $2.300M $1.300M
YoY Change 76.92% 62.5%
Inventory $26.09M $23.20M
Prepaid Expenses
Receivables $22.12M $11.07M
Other Receivables $500.0K $500.0K
Total Short-Term Assets $195.9M $217.9M
YoY Change -10.09% 133.67%
LONG-TERM ASSETS
Property, Plant & Equipment $16.00M $13.71M
YoY Change 16.7% -5.23%
Goodwill $60.98M $31.03M
YoY Change 96.54% 116.27%
Intangibles $29.01M $19.19M
YoY Change 51.22% 41.13%
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $6.380M $500.0K
YoY Change 1176.0% 0.0%
Total Long-Term Assets $112.8M $64.37M
YoY Change 75.27% 46.04%
TOTAL ASSETS
Total Short-Term Assets $195.9M $217.9M
Total Long-Term Assets $112.8M $64.37M
Total Assets $308.8M $282.3M
YoY Change 9.37% 105.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.951M $7.688M
YoY Change -9.59% 78.65%
Accrued Expenses $9.568M $13.66M
YoY Change -29.97% 18.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.52M $21.35M
YoY Change -22.63% 34.91%
LONG-TERM LIABILITIES
Long-Term Debt $97.20M $93.40M
YoY Change 4.07%
Other Long-Term Liabilities $1.616M $1.878M
YoY Change -13.95% -43.03%
Total Long-Term Liabilities $1.616M $1.878M
YoY Change -13.95% -43.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.52M $21.35M
Total Long-Term Liabilities $1.616M $1.878M
Total Liabilities $18.14M $23.23M
YoY Change -21.93% 21.47%
SHAREHOLDERS EQUITY
Retained Earnings -$48.36M -$66.05M
YoY Change -26.79% -11.16%
Common Stock $248.0M $239.0M
YoY Change 3.77% 19.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $190.9M $163.7M
YoY Change
Total Liabilities & Shareholders Equity $308.8M $282.3M
YoY Change 9.37% 105.55%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $8.438M $3.872M
YoY Change 117.92% 7.17%
Depreciation, Depletion And Amortization $1.700M $1.320M
YoY Change 28.79% 14.78%
Cash From Operating Activities $2.810M $10.56M
YoY Change -73.39% 42.51%
INVESTING ACTIVITIES
Capital Expenditures -$1.380M -$980.0K
YoY Change 40.82% 108.51%
Acquisitions
YoY Change
Other Investing Activities $9.440M -$200.0K
YoY Change -4820.0% -128.99%
Cash From Investing Activities $8.050M -$1.180M
YoY Change -782.2% -636.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 160.0K 111.5M
YoY Change -99.86% 38334.48%
NET CHANGE
Cash From Operating Activities 2.810M 10.56M
Cash From Investing Activities 8.050M -1.180M
Cash From Financing Activities 160.0K 111.5M
Net Change In Cash 11.02M 120.8M
YoY Change -90.88% 1425.76%
FREE CASH FLOW
Cash From Operating Activities $2.810M $10.56M
Capital Expenditures -$1.380M -$980.0K
Free Cash Flow $4.190M $11.54M
YoY Change -63.69% 46.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
37356123 shares
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172622000
CY2017Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
2 Investment
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
20.04
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34118994 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
790545 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1483367 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34118994 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
439980 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.98
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
803532 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.16
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q2 us-gaap Share Price
SharePrice
41.44
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48355000
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1616000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2567000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
308763000
CY2017Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
406000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4602000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
864000
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8671000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6951000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37079000
CY2017Q2 us-gaap Assets
Assets
308763000
CY2017Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
659000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
190943000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1355000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2567000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2707000
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
204000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
341000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
247628000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21083000
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1505000
CY2017Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2567000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8458000
CY2017Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2457000
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
32000
CY2017Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
539000
CY2017Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
745000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
16519000
CY2017Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97228000
CY2017Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
450000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9568000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
195945000
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2461000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15996000
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
11695000
CY2017Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2744000
CY2017Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
1498000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142207000
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14437000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2388000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29013000
CY2017Q2 us-gaap Inventory Net
InventoryNet
26085000
CY2017Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
16921000
CY2017Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22115000
CY2017Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1604000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1708000
CY2017Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3732000
CY2017Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
16471000
CY2017Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
534000
CY2017Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2227000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2870000
CY2017Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2904000
CY2017Q2 us-gaap Goodwill
Goodwill
60979000
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
37471000
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7086000
CY2017Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
16538000
CY2017Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
15272000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6380000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2260000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17145000
CY2017Q2 rgen Operating Lease Future Minimum Payments Due In Four Years And Thereafter
OperatingLeaseFutureMinimumPaymentsDueInFourYearsAndThereafter
1812000
CY2017Q2 rgen Impact Of Credit Risk On Fair Value Of Derivatives
ImpactOfCreditRiskOnFairValueOfDerivatives
0
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54092000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33844074 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33844074 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
882748 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.88
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59861000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1699000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
288913000
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
435000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5586000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
408000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13749000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5061000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
382000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
168764000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
204000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
338000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
242036000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19332000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
411000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6695000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2103000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23000
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1692000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
964000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21075000
CY2016Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6119000
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
95272000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
6119000
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
248000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16014000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
184153000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2789000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14956000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
19547000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122233000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29806000
CY2016Q4 us-gaap Inventory Net
InventoryNet
24696000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15194000
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1264000
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
3218000
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
15214000
CY2016Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
839000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34288000
CY2016Q4 us-gaap Assets
Assets
288913000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0
CY2016Q4 us-gaap Goodwill
Goodwill
59548000
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
36501000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6953000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14954000
CY2016Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14592000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1644000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
222001 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P13Y
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
3961000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
31157 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M25D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.04
dei Trading Symbol
TradingSymbol
RGEN
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34715797 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33995323 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y8M16D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.94
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="PAGE-BREAK-INSIDE: avoid"> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"><b>Basis of Presentation</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The condensed consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company,&#x201D; &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for Quarterly Reports on Form <font style="WHITE-SPACE: nowrap">10-Q</font> and Article 10 of Regulation <font style="WHITE-SPACE: nowrap">S-X</font> and do not include all of the information and footnote disclosures required by U.S. GAAP. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Annual Report on Form <font style="WHITE-SPACE: nowrap">10-K</font> for the fiscal year ended December&#xA0;31, 2016.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Repligen Sweden AB (&#x201C;Repligen Sweden&#x201D;), Repligen GmbH (acquired as Atoll GmbH as of April&#xA0;1, 2016 and renamed on September&#xA0;20, 2016), Repligen Singapore Pte. Ltd. and our former subsidiary, TangenX Technology Corporation (acquired as of December&#xA0;14, 2016 and merged into the Company as of June&#xA0;30, 2017). All significant intercompany accounts and transactions have been eliminated in consolidation.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <i>Recently Issued Accounting Pronouncements</i></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> In May 2014, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No.&#xA0;2014-09,</font> &#x201C;Revenue from Contracts with Customers (Topic 606),&#x201D; which supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, <i>Revenue Recognition</i>, and creates a new Topic 606, <i>Revenue from Contracts with Customers</i>. Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The adoption of this ASU will include updates as provided under ASU <font style="WHITE-SPACE: nowrap">2015-14,</font> &#x201C;Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date&#x201D;;&#xA0;ASU <font style="WHITE-SPACE: nowrap">2016-08,</font> &#x201C;Revenue from Contracts with Customers (Topic&#xA0;606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net)&#x201D;; ASU <font style="WHITE-SPACE: nowrap">2016-10,</font> &#x201C;Revenue from Contracts with Customers (Topic&#xA0;606): Identifying Performance Obligations and Licensing&#x201D;; and ASU <font style="WHITE-SPACE: nowrap">2016-12,</font> &#x201C;Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#x201D; The Company intends to adopt the provisions of Topic 606 using the modified retrospective method effective January&#xA0;1, 2018. The Company has made substantial progress with its assessment of the impact of the new revenue standard on its current contracts and principal revenue streams. Following the closing of the acquisition of Spectrum, Inc. (&#x201C;Spectrum&#x201D;), the Company will also need to assess the potential impact on the Spectrum revenue arrangements. Additionally, the Company will begin to update its revenue recognition policies and procedures and develop a framework for the newly required financial statement disclosures during the third quarter of 2017 to prepare for the adoption of this standard. The Company has not made a determination on the impact to its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In July 2015, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No.&#xA0;2015-11,</font> &#x201C;Inventory (Topic 330): Simplifying the Measurement of Inventory&#x201D; (&#x201C;ASU <font style="WHITE-SPACE: nowrap">2015-11&#x201D;).</font> ASU <font style="WHITE-SPACE: nowrap">2015-11</font> requires inventory be measured at the lower of cost and net realizable value, and options that currently exist for market value be eliminated. ASU <font style="WHITE-SPACE: nowrap">2015-11</font> defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective prospectively for reporting periods beginning after December&#xA0;15, 2016 and interim periods within those fiscal years with early adoption permitted. The Company adopted the provisions of ASU <font style="WHITE-SPACE: nowrap">2015-11</font> as of January&#xA0;1, 2017, and this standard did not have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In February 2016, the FASB issued ASU No. <font style="WHITE-SPACE: nowrap">2016-02,&#xA0;&#x201C;Leases</font> (Topic 842)&#x201D; (&#x201C;ASU <font style="WHITE-SPACE: nowrap">2016-02&#x201D;).</font> ASU <font style="WHITE-SPACE: nowrap">2016-02</font> requires lessees to recognize a <font style="WHITE-SPACE: nowrap"><font style="WHITE-SPACE: nowrap">right-of-use</font></font> asset and a lease liability for most leases. Extensive quantitative and qualitative disclosures, including significant judgments made by management, will be required to provide greater insight into the extent of revenue and expense recognized and expected to be recognized from existing contracts. The accounting applied by a lessor is largely unchanged from that applied under the current standard. The standard must be adopted using a modified retrospective transition approach and provides for certain practical expedients. This ASU is effective for public entities for fiscal years beginning after December&#xA0;15, 2018, with early adoption permitted. The Company has not yet completed its assessment of the impact of the new standard on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt"> In March 2016, the FASB issued ASU No. <font style="WHITE-SPACE: nowrap">2016-09,&#xA0;&#x201C;Compensation&#x2014;Stock</font> Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting&#x201D;, which aims to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, classification of certain items on the statement of cash flows and accounting for forfeitures. This ASU is effective for public entities for fiscal years beginning after December&#xA0;15, 2016, with early adoption permitted. The Company adopted the provisions of this ASU as of January&#xA0;1, 2017. As a result of this standard, the Company increased its U.S. federal and state net operating loss carryovers by approximately $5.3&#xA0;million for previously unrecognized excess tax benefits outstanding as of January&#xA0;1, 2017. Since the Company maintained a full valuation allowance on its net U.S. deferred tax assets as of the adoption date, the Company recorded a corresponding increase to the valuation allowance and the impact of adopting ASU <font style="WHITE-SPACE: nowrap">2016-09</font> on retained earnings is zero.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In August 2016, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No.&#xA0;2016-15,</font> &#x201C;Statement of Cash Flows (Topic 203): Classification of Certain Cash Receipts and Cash Payments&#x201D;. ASU <font style="WHITE-SPACE: nowrap">No.&#xA0;2016-15</font> addresses eight specific cash flow issues and clarifies their presentation and classification in the Statement of Cash Flows. This ASU is effective for fiscal years beginning after December&#xA0;15, 2017 and is to be applied retrospectively with early adoption permitted. The Company currently classifies payments up to the amount of its contingent consideration liability recognized at the date of its acquisition as financing activities, with additional payments classified as operating activities. As a result, the Company does not expect the adoption of ASU <font style="WHITE-SPACE: nowrap">2016-15</font> to have a material impact on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In January 2017, the FASB issued ASU&#xA0;No. <font style="WHITE-SPACE: nowrap">2017-01,&#xA0;&#x201C;Business</font> Combinations (Topic 805): Clarifying the Definition of a Business&#x201D;, which clarifies the definition of a business to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. This ASU is effective for public entities for fiscal years beginning after December&#xA0;15, 2017, with early adoption permitted.</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> In January 2017, the FASB issued ASU <font style="WHITE-SPACE: nowrap">No.&#xA0;2017-04,</font> &#x201C;Intangibles&#x2013;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,&#x201D; eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January&#xA0;1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company&#x2019;s consolidated financial statements.</p> </div>
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
33.38
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
433483 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
149903 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.490 pure
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M26D
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
286991 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
20.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
101844 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1734000
us-gaap Revenues
Revenues
63045000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2676000
us-gaap Investment Income Net
InvestmentIncomeNet
206000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
754000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
63003000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
42000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1677000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000
us-gaap Operating Income Loss
OperatingIncomeLoss
11150000
us-gaap Net Income Loss
NetIncomeLoss
11506000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
813000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6347000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16584000
us-gaap Royalty Revenue
RoyaltyRevenue
42000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5073000
us-gaap Income Taxes Paid
IncomeTaxesPaid
2150000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-448000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5078000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-226000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
236000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7721000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-64000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5384000
us-gaap Depreciation
Depreciation
1858000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2053000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3785000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1740000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
417279 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6753000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33862311 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.55
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33336989 shares
us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
us-gaap Interest Expense
InterestExpense
3187000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
14132000
us-gaap Share Based Compensation
ShareBasedCompensation
3027000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1956000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3278000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20367000
us-gaap Costs And Expenses
CostsAndExpenses
51895000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4216000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-172000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3602000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1484000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19974000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
27926000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
6119000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16850000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1505000
rgen Increase Decrease In Noncurrent Liabilities
IncreaseDecreaseInNoncurrentLiabilities
-86000
rgen Long Term Marketable Securities Maturities Term Minimum
LongTermMarketableSecuritiesMaturitiesTermMinimum
P1Y
rgen Marketable Debt Securities Weighted Average Remaining Maturity Period
MarketableDebtSecuritiesWeightedAverageRemainingMaturityPeriod
P2M
rgen Payment Of Contingent Consideration In Common Stock
PaymentOfContingentConsiderationInCommonStock
1062000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
525322 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.305 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1195000
us-gaap Revenues
Revenues
54265000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1406000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8767000
us-gaap Investment Income Net
InvestmentIncomeNet
137000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
15000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
54265000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
3952000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
498000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15000
us-gaap Operating Income Loss
OperatingIncomeLoss
9321000
us-gaap Net Income Loss
NetIncomeLoss
5496000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5093000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-892000
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4878000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-633000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1981000
us-gaap Stock Issued1
StockIssued1
14135000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-904000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
318000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-793000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7911000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-26000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2642000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
218000
us-gaap Depreciation
Depreciation
1535000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-26000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2415000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
511000
us-gaap Interest Expense
InterestExpense
643000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
20000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000
us-gaap Share Based Compensation
ShareBasedCompensation
2059000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
382000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2465000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
111323000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15159000
us-gaap Costs And Expenses
CostsAndExpenses
44944000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3239000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
111783000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3430000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
932000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
118530000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
23713000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
958000
rgen Increase Decrease In Noncurrent Liabilities
IncreaseDecreaseInNoncurrentLiabilities
-66000
rgen Payment Of Contingent Consideration In Common Stock
PaymentOfContingentConsiderationInCommonStock
875000
CY2016 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P13Y
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
359828 shares
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2016Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34175127 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33649296 shares
CY2016Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
525831 shares
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.279 pure
CY2016Q2 us-gaap Revenues
Revenues
29170000
CY2016Q2 us-gaap Investment Income Net
InvestmentIncomeNet
76000
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
29170000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5859000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
3872000
CY2016Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1358000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2514000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5372000
CY2016Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
637000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1500000
CY2016Q2 us-gaap Interest Expense
InterestExpense
638000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1137000
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8140000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
23311000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1890000
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
12644000
CY2017Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
187072 shares
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2017Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35094814 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34097805 shares
CY2017Q2 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
0 shares
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2017Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
437427 shares
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-1.309 pure
CY2017Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
559582 shares
CY2017Q2 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9200000
CY2017Q2 us-gaap Revenues
Revenues
32455000
CY2017Q2 us-gaap Investment Income Net
InvestmentIncomeNet
110000
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
32434000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5473000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
8438000
CY2017Q2 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
12484000
CY2017Q2 us-gaap Royalty Revenue
RoyaltyRevenue
21000
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4046000
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-328000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3654000
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4784000
CY2017Q2 us-gaap Interest Expense
InterestExpense
1601000
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1496000
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11185000
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
26982000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1860000
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
13937000

Files In Submission

Name View Source Status
0001193125-17-247408-index-headers.html Edgar Link pending
0001193125-17-247408-index.html Edgar Link pending
0001193125-17-247408.txt Edgar Link pending
0001193125-17-247408-xbrl.zip Edgar Link pending
d601196d10q.htm Edgar Link pending
d601196dex311.htm Edgar Link pending
d601196dex312.htm Edgar Link pending
d601196dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20170630.xml Edgar Link completed
rgen-20170630.xsd Edgar Link pending
rgen-20170630_cal.xml Edgar Link unprocessable
rgen-20170630_def.xml Edgar Link unprocessable
rgen-20170630_lab.xml Edgar Link unprocessable
rgen-20170630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending